Is Biotech in a Bubble?

Learn more about this firm

Portfolio Manager Carl Brown discusses valuations in the biotech industry. What does he look for in an area that led the market before correcting in 2015's third quarter?

Related Commentary:

Staying Diversified in the Pursuit of Sustainable Growth

What Makes The Current Market Cycle Unique?